Andrew Sharabi MD
Associate Professor and Director of the Center for Precision Radiation Medicine
Join to View Full Profile
3855 Health Sciences DrLa Jolla, CA 92093
Dr. Sharabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2011 - 2015
Houston Methodist Hospital (Medical Center)Internship, Transitional Year, 2010 - 2011
Baylor College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation Start of enrollment: 2015 Jan 07
- Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease Start of enrollment: 2016 Sep 02
- SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2017 Oct 26
Publications & Presentations
PubMed
- HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.Souvick Roy, Sayuri Miyauchi, Riley N Jones, Sangwoo S Kim, Aldo Venuti
Cancer Research. 2025-10-15 - Assessing dosimetric benefit from daily online adaptive radiation therapy for esophageal cancer.Antonia Kubiatowicz, Michael Sherer, Ayaka Owaga, Andrew Sharabi, Xenia Ray
Journal of Applied Clinical Medical Physics. 2025-10-01 - Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.Maria Gabriella Donà, Francesca Paolini, Maria Benevolo, Francesca Rollo, Elisabetta Merenda
BMC Cancer. 2025-08-07
Press Mentions
Synergistic Treatment Approach Supercharges Cancer ImmunotherapyJuly 29th, 2025- News & PublicationsMay 1st, 2024
- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
